Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Pain|July 28, 2004
Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic painLowell Reynolds, Richard Rauck, Lynn Webster, et al.
The Journal of Rheumatology|June 7, 2007
Preliminary development of a responder index for chronic low back painLee S Simon, Christopher Evans, Nathaniel Katz, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2009
Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006Nathaniel Katz, Lee Panas, Meelee Kim, et al.
Pain|April 29, 2015
Efficacy and safety of tanezumab in the treatment of pain from bone metastasesMaciej Sopata, Nathaniel Katz, William Carey, et al.
Lancet (London, England)|March 29, 2026
Efficacy and safety of LEVI-04 in patients with osteoarthritis of the knee: a randomised, double-blind, placebo-controlled, phase 2 trialPhilip G Conaghan, Nathaniel Katz, Asger R Bihlet, et al.
Pain Medicine (Malden, Mass.)|March 10, 2020
Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back PainJack E Henningfield, Jeffrey Gudin, Richard Rauck, et al.
The Journal of Pain|October 18, 2016
Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled StudyDavid M Simpson, Jessica Robinson-Papp, Joanna Van, et al.
Osteoarthritis and Cartilage|December 29, 2024
Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trialPhilip G Conaghan, Nathaniel Katz, David J Hunter, et al.
Pharmacoepidemiology and Drug Safety|October 22, 2008
National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuseStephen F Butler, Simon H Budman, Andrea Licari, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Pageof 7